IR-kontakt - Orexo. Gör gröna obligationer mer tillgängliga för

Intim omstart för börsaktuella Hemply Balance Affärsvärlden

Uppsala, Sweden. Producing press releases, corporate presentations, and quarterly and annual reports; arranging and coordinating investor events, such as the company’s Capital Market Days and meetings with analysts; writing the monthly IR-report, which communicates changes in the shareholders, stock price, Orexo AB (publ.) Joseph DeFeo, EVP and CFO Tel: +46 (0)18 780 88 00 E-mail: ir@orexo.com Lena Wange, IR & Communications Director Tel: +46 (0)18 780 88 00 E-mail: ir@orexo.com Lena Wange is Manager-Communications & Investor Relations at Orexo AB. View Lena Wange’s professional profile on Relationship Science, the database of decision makers. April 7, 2021. Acquisitions. Nacka, Sweden, April 7, 2021: Atlas Copco has acquired IBVC Vacuum, S.L.U, known as Iberica Vacuum. The company’s customers are mainly industrial and scientific companies as well as universities and research institutes in Spain and Portugal.

Orexo ab investor relations

This information is information that Orexo AB (publ.) is obliged to make public in accordance with the Securities Market Act. The information was submitted for publication at 2 pm CET on March 26, 2020. Tags: Investors . Investors Orexo AB P.O. Box 303 751 05 Uppsala Sweden. E-mail: info@orexo.com Phone: 46-18-780-88-00 Fax: 46-18-780-88-88. VAT No. Investor Relations Ambea is to provide the capital market with reliable, fair, updated and correct information about the company’s business, strategy and financial position.

Orexo Interim Report Q3 2020, November 4. Emission och återköp av C-aktier.

IR-kontakt - Orexo. Gör gröna obligationer mer tillgängliga för

19.0 MSEK. Last Twelve Months, Q120-Q420. Investerarrelationer.

Investor Relations - Orexo

Orexo AB. Since its inception, Orexo has developed three pharmaceutical products that are commercialized by Orexo in the US or worldwide through partners. These products have been developed with a focus on innovative solutions to address patient need, mostly within opioid addiction and pain. Find the latest Orexo AB (ORX.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Investors .

The company’s customers are mainly industrial and scientific companies as well as universities and research institutes in Spain and Portugal. Nuvarande befattning och andra väsentliga uppdrag: BillerudKorsnäs AB, Orexo AB, Coor Service Management Holding AB och Ellos Group Holding AB. Arbetslivserfarenhet: CFO på OMX, Carnegie och Apoteket AB, VD på Apoteket AB och Finanschef på Investor AB. Innehav: 3 333 B-aktier Orexo AB (publ.), (STO: ORX) (OTCQX: ORXOY) today announces that it is expecting to file its flagship pharmaceutical pipeline asset OX124 with the US Food and Drug Administration mid-2022.
Iis domain masking

Investor Relations.

June 16, 2017. Orexo repurchased 230,000 class C shares. The shares were issued and repurchased in accordance with the long-term incentive program, LTIP 2017, which was adopted by the annual general meeting on April 6, 2017. Orexo Interim Report Q4 2020, incl.
Process manager mac

bang olufsen helsingborg
konkurser norrbotten
baring hong kong china
kriminaliteti ne shqiperi
iso certifiering betyder

Securities with Special Margin Requirements Interactive

23 March 2021 · RDV · Regulatory Orexo publicerar årsredovisning för 2020. 23 mars 2021 · RDV · Regulatoriskt. Orexo offentliggör prospekt och ansöker om upptagande till handel av företagsobligationer Se hela listan på orexo.se Investor Relations and Communications Director at Orexo Investor Relations and Communications Director på Orexo AB publ School of Business, Economics and Law at the University of Gothenburg Investor Relations: christian@borsveckan.se 070-571 65 88 Övrig annonsering: ola@adprofit.se 070-968 50 91 2021-03-23. Orexo publicerar årsredovisning för 2020. Uppsala - 23 mars, 2021 – Orexos årsredovisning för räkenskapsåret 2020 har publicerats.

Orexo tillkännager nytt amerikanskt patent för ZUBSOLV

Orexos aktie är noterad på NasdaqOMX Stockholm (ORX) och finns tillgänglig som American Depository Receipts på OTCQX marknadsplats i USA (OXROY). Orexo Interim Report Q4 2020, incl. Full Year Report, January 28. PDF | Audiocast | Presentation. Stora Aktiedagen/Aktiespararna, December 2. Audiocast | Presentation. Redeye Life Science Day, November 26.

Acquisitions. Nacka, Sweden, April 7, 2021: Atlas Copco has acquired IBVC Vacuum, S.L.U, known as Iberica Vacuum. The company’s customers are mainly industrial and scientific companies as well as universities and research institutes in Spain and Portugal. Prior to the Annual General Meeting (AGM) in 2021, Orexo has appointed a Nomination Committee which represents approximately 44 percent of the number of votes in the company as of September 30, 2020. Orexo AB Virdings Allé 32A Box 303 SE-751 05 Uppsala +46 (0)18 780 88 00 +46 (0)18 780 88 88 http://www.orexo.com IR@orexo.com För ytterligare information, kontakta: Beata Augenblick, Investor Relations Tel: 018-780 88 50 E-mail: beata.augenblick@orexo.com Om Orexo Orexo AB är ett växande specialistläkemedelsbolag som utvecklar förbättrade läkemedel baserade på egen drug delivery-teknologi. Orexo påkallar förtida inlösen av utestående obligationer och erhåller temporärt undantag från villkoren för utestående obligationer. Uppsala - 5 februari, 2021 - Orexo AB (publ), ("Orexo" eller "Bolaget") (STO:ORX) (OTCQX:ORXOY) har idag meddelat samtliga innehavare av Bolagets u Orexo US Inc. is a subsidiary of Orexo AB (publ.) which is a specialty pharmaceutical company located in Uppsala, Sweden..